{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:58:27Z","timestamp":1790823507868,"version":"4.1.0"},"reference-count":25,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Nightingale Health Plc"}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Biomarkers of low-grade inflammation have been associated with susceptibility to a severe infectious disease course, even when measured prior to disease onset. We investigated whether metabolic biomarkers measured by nuclear magnetic resonance (NMR) spectroscopy could be associated with susceptibility to severe pneumonia (2507 hospitalised or fatal cases) and severe COVID-19 (652 hospitalised cases) in 105,146 generally healthy individuals from UK Biobank, with blood samples collected 2007\u20132010. The overall signature of metabolic biomarker associations was similar for the risk of severe pneumonia and severe COVID-19. A multi-biomarker score, comprised of 25 proteins, fatty acids, amino acids, and lipids, was associated equally strongly with enhanced susceptibility to severe COVID-19 (odds ratio 2.9 [95%CI 2.1\u20133.8] for highest vs lowest quintile) and severe pneumonia events occurring 7\u201311 years after blood sampling (2.6 [1.7\u20133.9]). However, the risk for severe pneumonia occurring during the first 2 years after blood sampling for people with elevated levels of the multi-biomarker score was over four times higher than for long-term risk (8.0 [4.1\u201315.6]). If these hypothesis generating findings on increased susceptibility to severe pneumonia during the first few years after blood sampling extend to severe COVID-19, metabolic biomarker profiling could potentially complement existing tools for identifying individuals at high risk. These results provide novel molecular understanding on how metabolic biomarkers reflect the susceptibility to severe COVID-19 and other infections in the general population.<\/jats:p>","DOI":"10.7554\/elife.63033","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T08:06:31Z","timestamp":1620115591000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.63033","source":"Crossref","is-referenced-by-count":192,"title":["Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population"],"prefix":"10.7554","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4282-0248","authenticated-orcid":true,"given":"Heli","family":"Julkunen","sequence":"first","affiliation":[{"name":"Nightingale Health Plc, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cicho\u0144ska","sequence":"additional","affiliation":[{"name":"Nightingale Health Plc, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P Eline","family":"Slagboom","sequence":"additional","affiliation":[{"name":"Molecular Epidemiology, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands"},{"name":"Max Planck Institute for Biology of Ageing, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5832-0221","authenticated-orcid":true,"given":"Peter","family":"W\u00fcrtz","sequence":"additional","affiliation":[{"name":"Nightingale Health Plc, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Nightingale Health UK Biobank Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4374","published-online":{"date-parts":[[2021,5,4]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1007\/s00125-019-05001-w","article-title":"Circulating metabolites and the risk of type 2 diabetes: a prospective study of 11,896 young adults from four finnish cohorts","volume":"62","author":"Ahola-Olli","year":"2019","journal-title":"Diabetologia"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1126\/science.abb0762","article-title":"Aging immunity may exacerbate COVID-19","volume":"369","author":"Akbar","year":"2020","journal-title":"Science"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000479089","article-title":"Risk factors for Community-Acquired pneumonia in adults: a systematic review of observational studies","volume":"94","author":"Almirall","year":"2017","journal-title":"Respiration"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1093\/gerona\/glaa183","article-title":"Preexisting comorbidities predicting COVID-19 and mortality in the UK biobank community cohort","volume":"75","author":"Atkins","year":"2020","journal-title":"The Journals of Gerontology: Series A"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cytogfr.2020.04.005","article-title":"Inflamm-aging: why older men are the most susceptible to SARS-CoV-2 complicated outcomes","volume":"53","author":"Bonaf\u00e8","year":"2020","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"bib6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11311-9","article-title":"A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals","volume":"10","author":"Deelen","year":"2019","journal-title":"Nature Communications"},{"key":"bib7","doi-asserted-by":"publisher","DOI":"10.1101\/2020.11.09.20228221","article-title":"The metabolic fingerprint of COVID-19 severity","volume-title":"medRxiv","author":"Dierckx","year":"2020"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","article-title":"Comparison of Sociodemographic and Health-Related characteristics of UK biobank participants with those of the general population","volume":"186","author":"Fry","year":"2017","journal-title":"American Journal of Epidemiology"},{"key":"bib9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19478-2","article-title":"Collider Bias undermines our understanding of COVID-19 disease risk and severity","volume":"11","author":"Griffith","year":"2020","journal-title":"Nature Communications"},{"key":"bib10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-040402","article-title":"Modifiable and non-modifiable risk factors for COVID-19, and comparison to risk factors for influenza and pneumonia: results from a UK biobank prospective cohort study","volume":"10","author":"Ho","year":"2020","journal-title":"BMJ Open"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.jacc.2017.12.006","article-title":"Lipids, lipoproteins, and metabolites and\u00a0Risk of Myocardial Infarction and\u00a0Stroke","volume":"71","author":"Holmes","year":"2018","journal-title":"Journal of the American College of Cardiology"},{"key":"bib12","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.02.20143685","article-title":"Blood biomarker score identifies individuals at high risk for severe COVID-19 a decade prior to diagnosis: metabolic profiling of 105,000 adults in the UK biobank","volume-title":"medRxiv","author":"Julkunen","year":"2020"},{"key":"bib13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117788","article-title":"The role of biomarkers in diagnosis of COVID-19 - A systematic review","volume":"254","author":"Kermali","year":"2020","journal-title":"Life Sciences"},{"key":"bib14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)33067-8","article-title":"UK Biobank, big data, and the consequences of non-representativeness","volume":"393","author":"Keyes","year":"2019","journal-title":"The Lancet"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nature Genetics"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2020.06.017","article-title":"Cytokine storms: understanding COVID-19","volume":"53","author":"Mangalmurti","year":"2020","journal-title":"Immunity"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cels.2020.05.012","article-title":"Ultra-High-Throughput clinical proteomics reveals classifiers of COVID-19 infection","volume":"11","author":"Messner","year":"2020","journal-title":"Cell Systems"},{"key":"bib18","article-title":"COVID-19 test results data","author":"Resource UKBiobankD","year":"2020","unstructured":"Resource UKBiobankD. 2020. COVID-19 test results data. http:\/\/biobank.ctsu.ox.ac.uk\/crystal\/exinfo.cgi?src=COVID19_tests; [Accessed February 3, 2021]."},{"key":"bib19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cels.2015.09.007","article-title":"The biomarker GlycA is associated with chronic inflammation and predicts Long-Term risk of severe infection","volume":"1","author":"Ritchie","year":"2015","journal-title":"Cell Systems"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2020.05.032","article-title":"Proteomic and metabolomic characterization of COVID-19 patient sera","volume":"182","author":"Shen","year":"2020","journal-title":"Cell"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1161\/CIRCGENETICS.114.000216","article-title":"Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics","volume":"8","author":"Soininen","year":"2015","journal-title":"Circulation: Cardiovascular Genetics"},{"key":"bib22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLOS Medicine"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"OpenSAFELY: factors associated with COVID-19 death in 17 million patients","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/aje\/kwx016","article-title":"Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies","volume":"186","author":"W\u00fcrtz","year":"2017","journal-title":"American Journal of Epidemiology"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"The Lancet"}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/63033\/elife-63033-v2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/63033\/elife-63033-v2.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/63033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T21:04:11Z","timestamp":1697058251000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/63033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":25,"alternative-id":["10.7554\/eLife.63033"],"URL":"https:\/\/doi.org\/10.7554\/elife.63033","archive":["CLOCKSS"],"relation":{"is-supplemented-by":[{"id-type":"accession","id":"220","asserted-by":"subject"}],"has-review":[{"id-type":"doi","id":"10.7554\/eLife.63033.sa1","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.63033.sa2","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.07.02.20143685","asserted-by":"object"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,4]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"e63033"}}